Kyle Preston is an accomplished technology leader with extensive experience in optical engineering and biosensing technologies. Currently serving as the Director of Chips and Sensors at SiPhox Health since June 2022, Kyle focuses on technology development and signal processing for biomarker measurements. Prior roles include positions at Quantum-Si, where Kyle was Photonics Design Lead and Senior Principal Engineer, overseeing product integration for next-generation single-molecule protein sequencing that contributed to the company's public offering exceeding $1 billion. Kyle's career also encompasses consulting for Identifeye Health, R&D at Tornado Spectral Systems, and academic research at Cornell University, yielding a Ph.D. in Electrical and Computer Engineering.